MetLife Investment Advisors »

Inhibrx Biosciences shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $92k 5.9k 15.66
2024-06-30 $68k 4.8k 14.17